Back to Trials
NCT04527315RecruitingAccepts Healthy Volunteers

COVID-19 Survivorship Registry

NYU Langone Health

Start Date

7/17/2020

Completion Date

12/1/2027

Summary

COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.

Detailed Description

The objectives for this study include providing structural and function information about lung and heart using chest imaging, MRI, Echo, Spirometry, and blood markers in order to assess severity of cardiopulmonary injury and short- and long-term sequelae of COVID-19 infection as well as assess indicators of mental health and quality of life.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * have tested positive for SARS-CoV-2 and discharged from the ICU or, * have tested positive for SARS-CoV-2 and have been discharged from hospital or, * have tested positive for SARS-CoV-2 but was NOT hospitalized * ages 18 and over, and * competent and willing to sign informed consent and comply to all aspects of the protocol CONTROL Inclusion Criteria * No clinical history of COVID-19, * No active clinical symptoms indicative of possible COVID-19, * Ages 18 and over, * competent and willing to sign informed consent and comply to all aspects of the protocol Exclusion Criteria: • Participants cannot sign consent Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study: * Participants who are pregnant or currently trying to get pregnant * Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants) * Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning. CONTROL Exclusion Criteria Patients with any of the following are excluded from as controls: * Pace maker * Poorly controlled diabetes * Poorly controlled Restrictive lung disease * Heart failure * Parkinson's Disease * Hypertension * Any diagnosis or history of autonomic neuropathy

Interventions

OTHER

Questionnaires

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Covid19

Locations

NYU Langone Health

New York, New York 10016

United States